vTv Therapeutics Inc sell tamam
Start price
18.04.18
/
50%
€2.07
Target price
31.05.18
€1.08
Performance (%)
-7.83%
End price
31.05.18
€1.91
Summary
This prediction ended on 31.05.18 with a price of €1.91. With a performance of -7.83%, the SELL prediction by tamam was trending in the right direction. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| vTv Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % | 52,38 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % | 72,45 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % | 57,58 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % | 62,15 % |
Comments by tamam for this prediction
In the thread vTv Therapeutics Inc diskutieren
vTv Therapeutics' azeliragon flunks late-stage Alzheimer's study
Bottom feeders have stampeded into fallen biotech vTv Therapeutics
(Vom Mitglied beendet)